Computational Design and Evaluation of Peptides to Target SARS-CoV-2 Spike–ACE2 Interaction
Molecules · 2025
DOI: 10.3390/molecules30081750 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Saja Almabhouh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Structural Bioinformatics Laboratory (GRIB-IMIM), Department of Medicine and Life Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Wellcome Trust, Ministerio de Ciencia, Innovación y Universidades.
Abstract (Originalsprache)
The receptor-binding domain (RBD) of SARS-CoV-2 spike protein is responsible for the recognition of the Angiotensin-Converting Enzyme 2 (ACE2) receptor in human cells and, thus, plays a critical role in viral infection. The therapeutic value of targeting this interaction has been proven by a sizable body of research investigating antibodies, small proteins, aptamers, and peptides. This study presents a novel peptide that impinges the interaction between RBD and ACE2. Starting from a very large pool of structurally designed peptides extracted from our database, PepI-Covid19, a diverse set of peptides were studied using molecular dynamics simulations. Ten of the most promising were chemically synthesized and validated both in vitro and in a cell-based assay. Our results indicate that one of the peptides (PEP10) exhibited the highest disruption of the RBD/ACE2 complex, effectively blocking the binding of two molecules and consequently inhibiting the SARS-CoV-2 spike-mediated cell entry of viruses pseudotyped with the spike of the D614G, Delta, and Omicron variants. PEP10 can potentially serve as a scaffold that can be further optimized for improved affinity and efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Structural Bioinformatics Laboratory (GRIB-IMIM), Department of Medicine and Life Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
- Institute Cochin, INSERM, CNRS, Université Paris Cité, F-75014 Paris, France.
- Synthetic Biology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
- GPCR Drug Discovery, Hospital del Mar Research Institute, 08003 Barcelona, Spain.
- Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, Aberystwyth SY23 3EE, UK.
ORCID-Profile: Erika Cecon, Florence Basubas, Tomasz Maciej Stepniewski, Jana Selent, Ralf Jockers, Baldo Oliva, Narcis Fernandez-Fuentes
Förderung
- Agence Nationale de la Recherche
- Wellcome Trust
- Ministerio de Ciencia, Innovación y Universidades
- Government of Catalonia
- Ser Cymru III
- La Marato
Zitieren
APA
Almabhouh, S., Cecon, E., Basubas, F., Molina-Fernandez, R., Maciej Stepniewski, T., Selent, J., Jockers, R., Rahmeh, A., Oliva, B., & Fernandez-Fuentes, N. (2025). Computational Design and Evaluation of Peptides to Target SARS-CoV-2 Spike–ACE2 Interaction. Molecules. https://doi.org/10.3390/molecules30081750
Vancouver
Almabhouh S, Cecon E, Basubas F, Molina-Fernandez R, Maciej Stepniewski T, Selent J, et al. Computational Design and Evaluation of Peptides to Target SARS-CoV-2 Spike–ACE2 Interaction. Molecules. 2025. doi:10.3390/molecules30081750
BibTeX
@article{Almabhouh2025,
author = {Almabhouh, Saja and Cecon, Erika and Basubas, Florence and Molina-Fernandez, Ruben and Maciej Stepniewski, Tomasz and Selent, Jana and Jockers, Ralf and Rahmeh, Amal and Oliva, Baldo and Fernandez-Fuentes, Narcis},
title = {Computational Design and Evaluation of Peptides to Target SARS-CoV-2 Spike–ACE2 Interaction},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30081750}
}
EUVIMED